Daniel A Anaya1, Avery B Nathens. 1. Division of General and Trauma Surgery, Harborview Medical Center, and the Department of Surgery, University of Washington, Seattle, Washington 98104-2499, USA.
Abstract
BACKGROUND: The incidence and risk factors for severe sepsis (SS, organ failure associated with infection) in the context of peritonitis are not well established; thus, it is not clear which patients require more aggressive operative or pharmacologic intervention. We set out to determine risk factors for severe sepsis in a large cohort of patients with intra-abdominal infection. METHODS: Patients admitted for peritonitis over a four-year interval were identified using a Washington State administrative hospital discharge database. This cohort was identified by ICD-9 CM diagnoses and diagnosis-related group (DRG) assignment. Patients with organ failure were identified by ICD-9 CM diagnoses codes using a previously validated classification scheme. Independent risk factors for SS were identified using stepwise Poisson regression. RESULTS: A total of 11,202 patients with peritonitis were identified, 11% of whom developed SS. The crude relative risk of death in patients with SS was 13 (95% CI, 11.1-15.2) times greater than those without. Severe sepsis was present in 424 (62%) of the 686 decedents. Multivariate analysis showed that source of infection, extent of peritonitis, increasing age, and pre-existing organ dysfunction were independently associated with SS. CONCLUSIONS: Severe sepsis complicates the course of 11% of all patients with peritonitis. Risk factor analysis identifies a subset of patients at greatest risk for severe sepsis. These are the patients who should be targeted for evaluation of novel pharmacologic interventions or more aggressive surgical intervention.
BACKGROUND: The incidence and risk factors for severe sepsis (SS, organ failure associated with infection) in the context of peritonitis are not well established; thus, it is not clear which patients require more aggressive operative or pharmacologic intervention. We set out to determine risk factors for severe sepsis in a large cohort of patients with intra-abdominal infection. METHODS:Patients admitted for peritonitis over a four-year interval were identified using a Washington State administrative hospital discharge database. This cohort was identified by ICD-9 CM diagnoses and diagnosis-related group (DRG) assignment. Patients with organ failure were identified by ICD-9 CM diagnoses codes using a previously validated classification scheme. Independent risk factors for SS were identified using stepwise Poisson regression. RESULTS: A total of 11,202 patients with peritonitis were identified, 11% of whom developed SS. The crude relative risk of death in patients with SS was 13 (95% CI, 11.1-15.2) times greater than those without. Severe sepsis was present in 424 (62%) of the 686 decedents. Multivariate analysis showed that source of infection, extent of peritonitis, increasing age, and pre-existing organ dysfunction were independently associated with SS. CONCLUSIONS: Severe sepsis complicates the course of 11% of all patients with peritonitis. Risk factor analysis identifies a subset of patients at greatest risk for severe sepsis. These are the patients who should be targeted for evaluation of novel pharmacologic interventions or more aggressive surgical intervention.
Authors: Amani D Politano; Tjasa Hranjec; Laura H Rosenberger; Robert G Sawyer; Carlos A Tache Leon Journal: Am Surg Date: 2011-07 Impact factor: 0.688
Authors: Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella Journal: J Immunol Date: 2011-10-03 Impact factor: 5.422
Authors: Christian P Schneider; Carol Seyboth; Markus Vilsmaier; Helmut Küchenhoff; Benjamin Hofner; Karl-Walter Jauch; Wolfgang H Hartl Journal: World J Surg Date: 2009-01 Impact factor: 3.352
Authors: Ilias I Siempos; Hilaire C Lam; Yan Ding; Mary E Choi; Augustine M K Choi; Stefan W Ryter Journal: J Vis Exp Date: 2014-02-09 Impact factor: 1.355
Authors: Brent C Opmeer; Kimberly R Boer; Oddeke van Ruler; Johannes B Reitsma; Hein G Gooszen; Peter W de Graaf; Bas Lamme; Michael F Gerhards; E Philip Steller; Cecilia M Mahler; Huug Obertop; Dirk J Gouma; Patrick Mm Bossuyt; Corianne Ajm de Borgie; Marja A Boermeester Journal: Crit Care Date: 2010-05-27 Impact factor: 9.097
Authors: Seonmin Lee; Seon-Jin Lee; Anna A Coronata; Laura E Fredenburgh; Su Wol Chung; Mark A Perrella; Kiichi Nakahira; Stefan W Ryter; Augustine M K Choi Journal: Antioxid Redox Signal Date: 2013-10-05 Impact factor: 8.401